<div class="article">
	<h3>Who's News:
   Wellcome PLC</h3>
	<div class="article-info">
		<ul>
			<li>Author: null</li>
			<li>Date: 06/14/90</li>
		</ul>
	</div>
	<p class="article-leader">WELLCOME PLC (London) -- James Cochrane, 46, and Keith
Merrifield, 48, have been appointed to the boards of both
this international pharmaceutical group and Wellcome
Foundation Ltd., the group's operating arm, effective in
August. Mr. Cochrane is currently president, Northern Europe,
of Bristol-Myers Squibb Co. On the retirement of Claude
Matons, he will be responsible for Wellcome's operations in
Europe and for Calmic International Ltd, a wholly owned
subsidiary of the group. Mr. Merrifield is currently managing
director of another unit, Wellcome International Trading
Ltd., and will become responsible for international
operations and Wellcome Environmental Health, a third unit.</p>
	<div class="article-body"><p></p></div>
</div>
